Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $150.0200 (-1.01%) ($149.9200 - $151.9050) on Thu. Aug. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.29% (three month average) | RSI | 47 | Latest Price | $150.0200(-1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(58%) DIA(52%) SPLV(51%) VYM(48%) IBB(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.645% in a week (0% probabilities). VXX(-34%) VIXM(-32%) USO(-18%) TBT(-14%) EDOC(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.645% (StdDev 1.29%) | Hourly BBV | -2.1 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $151.63(-1.06%) | 10 Day Moving Average | $150.85(-0.55%) | 20 Day Moving Average | $148.91(0.75%) | To recent high | -1.5% | To recent low | 13.2% | Market Cap | $264.678b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |